These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 32744317)

  • 1. Association of variant on the promoter of cluster of differentiation 74 in graves disease and graves ophthalmopathy.
    Liu YH; Shen CY; Tsai FJ
    Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32744317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role of
    Yaylacıoğlu Tuncay F; Serbest Ceylanoğlu K; Güntekin Ergün S; Ergün G; Konuk O
    Turk J Ophthalmol; 2024 Apr; 54(2):69-75. PubMed ID: 38645270
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Zhang M; Liu S; Xu J; Lv S; Fan Y; Zhang Y; Zhang Y; Wu Y; Su Y; Yu H; Song S; He J; Li H
    Curr Eye Res; 2020 Jul; 45(7):888-895. PubMed ID: 31869260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymorphisms of endothelin 1 (G5665T and T-1370G) and endothelin receptor type A (C+70G and G-231A) in Graves' disease.
    Aydın AF; Develi-İş S; Doğru-Abbasoğlu S; Vural P; Ozderya A; Karadağ B; Uysal M
    Int Immunopharmacol; 2014 Jan; 18(1):198-202. PubMed ID: 24291390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of FoxP3 promoter polymorphisms with the risk of Graves' disease in ethnic Kashmiri population.
    Shehjar F; Afroze D; Misgar RA; Malik SA; Laway BA
    Gene; 2018 Sep; 672():88-92. PubMed ID: 29890310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of Transcriptional Factors of T Helper Differentiation (T-bet, GATA-3, RORγt, and FOXP3), MIF Receptors (CD44, CD74, CXCR2, 4, 7), and Th1, Th2, and Th17 Cytokines in PBMC from Control Subjects and Rheumatoid Arthritis Patients.
    Zerpa-Hernández DA; García-Chagollán M; Sánchez-Zuno GA; García-Arellano S; Hernández-Bello J; Hernández-Palma LA; Cerpa-Cruz S; Martinez-Bonilla G; Nicoletti F; Muñoz-Valle JF
    Curr Mol Med; 2024; 24(9):1169-1182. PubMed ID: 37807647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrophage migration inhibitory factor confers resistance to senescence through CD74-dependent AMPK-FOXO3a signaling in mesenchymal stem cells.
    Xia W; Zhang F; Xie C; Jiang M; Hou M
    Stem Cell Res Ther; 2015 Apr; 6(1):82. PubMed ID: 25896286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The common -318C/T polymorphism in the promoter region of CTLA4 gene is associated with reduced risk of ophthalmopathy in Chinese Graves' patients.
    Han SZ; Zhang SH; Li R; Zhang WY; Li Y
    Int J Immunogenet; 2006 Aug; 33(4):281-7. PubMed ID: 16893393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD74 and macrophage migration inhibitory factor as therapeutic targets in gastric cancer.
    Zheng YX; Yang M; Rong TT; Yuan XL; Ma YH; Wang ZH; Shen LS; Cui L
    World J Gastroenterol; 2012 May; 18(18):2253-61. PubMed ID: 22611320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predisposition to Graves' disease and Graves' ophthalmopathy by genetic variants of IL2RA.
    Du J; Wang X; Tan G; Wei W; Zhou F; Liang Z; Li H; Yu H
    J Mol Med (Berl); 2021 Oct; 99(10):1487-1495. PubMed ID: 34287665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of the TSH receptor gene on susceptibility to Graves' disease and Graves' ophthalmopathy.
    Yin X; Latif R; Bahn R; Tomer Y; Davies TF
    Thyroid; 2008 Nov; 18(11):1201-6. PubMed ID: 18925838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targetted inhibition of CD74 attenuates adipose COX-2-MIF-mediated M1 macrophage polarization and retards obesity-related adipose tissue inflammation and insulin resistance.
    Chan PC; Wu TN; Chen YC; Lu CH; Wabitsch M; Tian YF; Hsieh PS
    Clin Sci (Lond); 2018 Jul; 132(14):1581-1596. PubMed ID: 29773671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression of macrophage migration inhibitory factor and CD74 in preeclamptic placenta and its correlation with preeclampsia].
    Xie XF; Zhan Y; Ye YH; Li C; Zhang Y
    Zhonghua Fu Chan Ke Za Zhi; 2010 Apr; 45(4):278-82. PubMed ID: 20646540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LPS-mediated cell surface expression of CD74 promotes the proliferation of B cells in response to MIF.
    Klasen C; Ziehm T; Huber M; Asare Y; Kapurniotu A; Shachar I; Bernhagen J; El Bounkari O
    Cell Signal; 2018 Jun; 46():32-42. PubMed ID: 29476963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Graves' disease and Graves' ophthalmopathy with the polymorphisms in promoter and exon 1 of cytotoxic T lymphocyte associated antigen-4 gene.
    Zhang Q; Yang YM; Lv XY
    J Zhejiang Univ Sci B; 2006 Nov; 7(11):887-91. PubMed ID: 17048303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single nucleotide polymorphisms at the PRR3, ABCF1, and GNL1 genes in the HLA class I region are associated with Graves' ophthalmopathy in a gender-dependent manner.
    Liu YH; Chen YJ; Wu HH; Wang TY; Tsai FJ
    Ophthalmology; 2014 Oct; 121(10):2033-9. PubMed ID: 24908204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual effect of a polymorphism in the macrophage migration inhibitory factor gene is associated with new-onset Graves disease in a Taiwanese Chinese population.
    Liu YH; Chen CC; Yang CM; Chen YJ; Tsai FJ
    PLoS One; 2014; 9(3):e92849. PubMed ID: 24667663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of polymorphisms of rs179247 and rs12101255 in thyroid stimulating hormone receptor intron 1 with an increased risk of Graves' disease: A meta-analysis.
    Gong J; Jiang SJ; Wang DK; Dong H; Chen G; Fang K; Cui JR; Lu FE
    J Huazhong Univ Sci Technolog Med Sci; 2016 Aug; 36(4):473-479. PubMed ID: 27465319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of CTLA-4 and IL-13 gene polymorphisms with Graves' disease and ophthalmopathy in Chinese children.
    Chong KK; Chiang SW; Wong GW; Tam PO; Ng TK; Hu YJ; Yam GH; Lam DS; Pang CP
    Invest Ophthalmol Vis Sci; 2008 Jun; 49(6):2409-15. PubMed ID: 18296657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MIF and D-DT are potential disease severity modifiers in male MS subjects.
    Benedek G; Meza-Romero R; Jordan K; Zhang Y; Nguyen H; Kent G; Li J; Siu E; Frazer J; Piecychna M; Du X; Sreih A; Leng L; Wiedrick J; Caillier SJ; Offner H; Oksenberg JR; Yadav V; Bourdette D; Bucala R; Vandenbark AA
    Proc Natl Acad Sci U S A; 2017 Oct; 114(40):E8421-E8429. PubMed ID: 28923927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.